Cargando…
Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning
BACKGROUND: The development of multi-drug resistant (MDR) cancer is a significant challenge in the clinical treatment of recurrent disease. Hypoxia is an environmental selection pressure that contributes to the development of MDR. Many cancer cells, including MDR cells, resort to glycolysis for ener...
Autores principales: | Milane, Lara, Duan, Zhenfeng, Amiji, Mansoor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045873/ https://www.ncbi.nlm.nih.gov/pubmed/21320311 http://dx.doi.org/10.1186/1475-2867-11-3 |
Ejemplares similares
-
Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer
por: Milane, Lara, et al.
Publicado: (2011) -
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
por: Huang, Dabing, et al.
Publicado: (2018) -
Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2010) -
Establishment of an orthotopic transplantation tumor model in nude mice using a drug-resistant human ovarian cancer cell line with a high expression of c-Kit
por: YI, CUNJIAN, et al.
Publicado: (2014) -
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
por: Milane, Lara, et al.
Publicado: (2021)